Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 3,155 shares at $15.17 ($48K) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Open-market sale of $48k GLUE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-06-18 | $57K | — | Filing → |
| GLUE | SELL | 2026-06-01 | $119K | — | Filing → |